Koers Beijing Science Sun Pharmaceutical Co., Ltd.
Aandelen
300485
CNE100002110
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,15 CNY | +1,75% | +8,23% | -23,04% |
Omzet 2022 | 735 mln. 102 mln. 94,63 mln. | Omzet 2023 | 477 mln. 66,03 mln. 61,39 mln. | Marktkapitalisatie | 5,1 mld. 707 mln. 657 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 205 mln. 28,4 mln. 26,41 mln. | Nettowinst (verlies) 2023 | 103 mln. 14,27 mln. 13,27 mln. | EV/omzet 2022 | 6,33 x |
Nettoliquiditeiten 2022 | 1,12 mld. 155 mln. 144 mln. | Nettoliquiditeiten 2023 | 1,17 mld. 163 mln. 151 mln. | EV/omzet 2023 | 8,24 x |
K/w-verhouding 2022 |
27,9
x | K/w-verhouding 2023 |
50,4
x | Werknemers | - |
Dividendrendement 2022 |
0,72% | Dividendrendement 2023 |
0,21% | Vrij verhandelbaar | 41,18% |
1 dag | +1,75% | ||
1 week | +8,23% | ||
Lopende maand | +6,54% | ||
1 maand | -4,34% | ||
3 maanden | +13,04% | ||
6 maanden | -28,51% | ||
Lopend jaar | -23,04% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 60 | 05-07-01 |
Ning Zhang
ADM | Chief Administrative Officer | 45 | 28-01-21 |
Meng Wei Song
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-03-01 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yan Heng Song
BRD | Director/Board Member | 51 | 26/01 |
Xue Feng Wang
BRD | Director/Board Member | 46 | 01-01-99 |
Biao Ma
CEO | Chief Executive Officer | 60 | 05-07-01 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 0 M€ | +3,53% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
07-05-24 | 8,15 | +1,75% | 6 081 968 |
06-05-24 | 8,01 | +4,71% | 6 755 220 |
30-04-24 | 7,65 | +1,59% | 4 639 700 |
slotkoers Shenzhen S.E., 07 mei 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-23,04% | 535 mln. | |
+33,43% | 690 mld. | |
+26,43% | 546 mld. | |
-5,12% | 358 mld. | |
+19,59% | 323 mld. | |
+4,89% | 287 mld. | |
+14,32% | 235 mld. | |
+5,79% | 199 mld. | |
-9,49% | 195 mld. | |
+4,26% | 161 mld. |